TNF Pharmaceuticals Inc. (TNFA)
NASDAQ: TNFA
· Real-Time Price · USD
3.51
-0.20 (-5.39%)
At close: Sep 23, 2025, 3:59 PM
3.50
-0.28%
After-hours: Sep 23, 2025, 07:56 PM EDT
-5.39% (1D)
| Bid | 3.46 |
| Market Cap | 6.2M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -6.91M |
| EPS (ttm) | -202 |
| PE Ratio (ttm) | -0.02 |
| Forward PE | n/a |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 3.55 |
| Volume | 164,864 |
| Avg. Volume (20D) | 615,698 |
| Open | 3.63 |
| Previous Close | 3.71 |
| Day's Range | 3.50 - 3.73 |
| 52-Week Range | 3.24 - 195.00 |
| Beta | 2.28 |
| Ex-Dividend Date | n/a |
About TNFA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TNFA
Website n/a
3 weeks ago
-31.56%
TNF Pharmaceuticals shares are trading lower after...
Unlock content with
Pro Subscription
7 months ago
-9.4%
TNF Pharmaceuticals shares are trading higher after the company announced that it initiated the first in a series of studies to evaluate the impact of isomyosamine.
2 weeks ago · businesswire.com
TNF Pharmaceuticals Announces Closing of $7 Million Private PlacementNEW YORK--(BUSINESS WIRE)---- $TNFA--TNF Pharmaceuticals, Inc. (Nasdaq: TNFA) (“TNF” or the “Company”) today announced the closing of a $7.0 million private placement financing of convertible preferre...
